Diltiazem co treatment with cyclosporine for induction of disease remission in sight-threatening non-infectious intraocular inflammation
Author:
- 10 December 2016
- journal article
- research article
- Published by Springer Nature in Japanese Journal of Ophthalmology
- Vol. 61 (2) , 169-178
Abstract
To investigate the effects of diltiazem co-treatment with microemulsified cyclosporine-A (CsA) on dosage, blood concentrations of CsA, as well as therapeutic and side effects in patients with sight-threatening non-infectious intraocular inflammation. A prospective, randomized, placebo-controlled, open-label trial of 39 patients with sight-threatening non-infectious intraocular inflammation. The change in visual acuity (LogMAR), the grade of inflammatory activity, therapeutic concentration of CsA in the blood and systemic and renal toxicity were determined after comparing two groups, one treated with CsA and diltiazem (treatment group), and the other without diltiazem (control group). Compared with the control group, the concentration of CsA in the blood of the treatment group significantly increased (P < 0.05) requiring a reduction in dosage of CsA (P < 0.05). In patients with severe intraocular inflammation treated with CsA and diltiazem, blood concentrations of CsA increased as the dosage decreased. This efficient combination therapy reduced patient's economic burden, at the same time decreasing systemic and renal toxicity which in turn may promote the use of CsA for longer periods.Keywords
This publication has 53 references indexed in Scilit:
- Use of calcium channel blockers for glaucomaProgress in Retinal and Eye Research, 2011
- Effects of Calcium Ion, Calpains, and Calcium Channel Blockers on Retinitis PigmentosaJournal of Ophthalmology, 2010
- Calcium channel blocker nilvadipine, but not diltiazem, inhibits ocular inflammation in endotoxin-induced uveitisJapanese Journal of Ophthalmology, 2010
- The effects of diltiazem in renal transplantation patients treated with cyclosporine AJournal of Biomedical Research, 2010
- Low-dose cyclosporine treatment for sight-threatening uveitis: Efficacy, toxicity, and toleranceIndian Journal Of Ophthalmology, 2010
- CyclosporinDrugs, 2001
- Diltiazem‐cyclosporin pharmacokinetic interaction — dose–response relationshipBritish Journal of Clinical Pharmacology, 1997
- Reversal activity of cyclosporin A and its metabolites M1, M17 and M21 in multidrug-resistant cellsInternational Journal of Cancer, 1997
- The Use of Other Drugs to Allow a Lower Dosage of Cyclosporin to Be UsedClinical Pharmacokinetics, 1997
- CYCLOSPORINE BLOOD CONCENTRATIONS IN THE MANAGEMENT OF RENAL TRANSPLANT RECIPIENTSTransplantation, 1986